Therapeutic potential of chemokine signal inhibition for metastatic breast cancer

Pharmacological Research

Volumn 100, Issue , 2015, Pages 266-270

  Kitamura, Takanori ^a   Pollard, Jeffrey W ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Breast cancer; Chemokine; Macrophage; Metastasis

Indexed keywords

BL 5923; CARLUMAB; CCX 140B; CCX 721; CCX 872; CHEMOKINE; CHEMOKINE RECEPTOR CCR1 ANTAGONIST; CHEMOKINE RECEPTOR CCR2 ANTAGONIST; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MNL 1202; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1 INHIBITOR; PLERIXAFOR; PROGRAMMED DEATH 1 RECEPTOR; SB 265610; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST METASTASIS; BREAST TUMOR; CANCER INHIBITION; DRUG BINDING SITE; DRUG POTENTIATION; DRUG PROTEIN BINDING; HUMAN; LUNG METASTASIS; MACROPHAGE; METASTASIS INHIBITION; MONOCYTE; MULTIPLE MYELOMA; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; ANIMAL; BREAST NEOPLASMS; DRUG EFFECTS; FEMALE; METABOLISM;

ANIMALS; BREAST NEOPLASMS; CHEMOKINES; FEMALE; HUMANS; MACROPHAGES; TUMOR MICROENVIRONMENT;

EID: 84940939272     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2015.08.004     Document Type: Article

References (52)

1. M.J. Hayat, N. Howlader, M.E. Reichman, and B.K. Edwards Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program Oncologist 12 2007 20 37
2. S. Dawood, K. Broglio, J. Ensor, G.N. Hortobagyi, and S.H. Giordano Survival differences among women with de novo stage IV and relapsed breast cancer Ann. Oncol. 21 2010 2169 2174
3. D. Hanahan, and L.M. Coussens Accessories to the crime: functions of cells recruited to the tumor microenvironment Cancer Cell 21 2012 309 322
4. D.F. Quail, and J.A. Joyce Microenvironmental regulation of tumor progression and metastasis Nat. Med. 19 2013 1423 1437
5. R. Noy, and J.W. Pollard Tumor- associated macrophages: from mechanisms to therapy Immunity 41 2014 49 61
6. T. Kitamura, B.Z. Qian, and J.W. Pollard Immune cell promotion of metastasis Nat. Rev. Immunol. 15 2015 73 86
7. F. Klemm, and J.A. Joyce Microenvironmental regulation of therapeutic response in cancer Trends Cell Biol. 25 2015 198 213
8. P. De, M. alma, and C.E. Lewis Macrophage regulation of tumor responses to anticancer therapies Cancer Cell 23 2013 277 286
9. B. Ruffell, and L.M. Coussens Macrophages and therapeutic resistance in cancer Cancer Cell 27 2015 462 472
10. B. Qian, Y. Deng, J.H. Im, R.J. Muschel, Y. Zou, J. Li, and et al. A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth PLoS One 4 2009 e6562
11. Q. Chen, X.H. Zhang, and J. Massagué Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs Cancer Cell 20 2011 538 549
12. B.Z. Qian, J. Li, H. Zhang, T. Kitamura, J. Zhang, L.R. Campion, and et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis Nature 475 2011 222 225
13. T. Kitamura, B.Z. Qian, D. Soong, L. Cassetta, R. Noy, G. Sugano, and et al. CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages J. Exp. Med. 212 2015 1043 1059
14. T. Ueno, M. Toi, H. Saji, M. Muta, H. Bando, K. Kuroi, and et al. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer Clin. Cancer Res. 6 2000 3282 3289
15. A. Kaufmann, R. Salentin, D. Gemsa, and H. Sprenger Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1α during differentiation of human monocytes to macrophages J. Leukoc Biol. 69 2001 248 252
16. R.E. Gerszten, E.A. Garcia-Zepeda, Y.C. Lim, M. Yoshida, H.A. Ding, M.A. Gimbrone Jr., and et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions Nature 398 1999 718 723
17. L. Sánchez-Martín, A. Estecha, R. Samaniego, S. Sánchez-Ramón, M.Á. Vega, and P. Sánchez-Mateos The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression Blood 117 2011 88 97
18. Y. Wu, Y.Y. Li, K. Matsushima, T. Baba, and N. Mukaida CCL3-CCR5 axis regulates intratumoral accumulation of leukocytes and fibroblasts and promotes angiogenesis in murine lung metastasis process J. Immunol. 181 2008 6384 6393
19. E.S. Nakasone, H.A. Askautrud, T. Kees, J.H. Park, V. Plaks, A.J. Ewald, and et al. Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance Cancer Cell 21 2012 488 503
20. S.T. Boyle, J.W. Faulkner, S.R. McColl, and M. Kochetkova The chemokine receptor CCR6 facilitates the onset of mammary neoplasia in the MMTV-PyMT mouse model via recruitment of tumor-promoting macrophages Mol. Cancer 14 2015 115
21. R.A. Franklin, W. Liao, A. Sarkar, M.V. Kim, M.R. Bivona, K. Liu, and et al. The cellular and molecular origin of tumor-associated macrophages Science 344 2014 921 925
22. P.J. Boimel, T. Smirnova, Z.N. Zhou, J. Wyckoff, H. Park, S.J. Coniglio, and et al. Contribution of CXCL12 secretion to invasion of breast cancer cells Breast Cancer Res. 14 2012 R23
23. J.R. Reed, M.D. Stone, T.C. Beadnell, Y. Ryu, T.J. Griffin, and K.L. Schwertfeger Fibroblast growth factor receptor 1 activation in mammary tumor cells promotes macrophage recruitment in a CX3CL1-dependent manner PLoS One 7 2012 e45877
24. L. Bonapace, M.M. Coissieux, J. Wyckoff, K.D. Mertz, Z. Varga, T. Junt, and et al. Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis Nature 515 2014 130 133
25. B. Sharma, K.C. Nannuru, M.L. Varney, and R.K. Singh Host Cxcr2 -dependent regulation of mammary tumor growth and metastasis Clin. Exp. Metastasis 32 2015 65 72
26. K.S. Shahneen, K. Papadopoulos, P.C. Fong, A. Patnaik, C. Messiou, D. Olmos, and et al. A first-in-human, first-in-class, phase I study of carlumab (CNTO888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors Cancer Chemother. Pharmacol. 71 2013 1041 1050
27. D.I. Jarmin, R.J. Nibbs, T. Jamieson, B. de, J.S. ono, and G.J. Graham Granulocyte macrophage colony-stimulating factor and interleukin-3 regulate chemokine and chemokine receptor expression in bone marrow macrophages Exp Hematol 27 1999 1735 1745
28. A.D. Joshi, S.R. Oak, A.J. Hartigan, W.G. Finn, S.L. Kunkel, K.E. Duffy, A. Das, and et al. Interleukin-33 contributes to both M1 and M2 chemokine marker expression in human macrophages BMC Immunol. 11 2010 52
29. M. Locati, U. Deuschle, M.L. Massardi, F.O. Martinez, M. Sironi, S. Sozzani, and et al. Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes J. Immunol. 168 2002 3557 3562
30. I.U. Schraufstatter, M. Zhao, S.K. Khaldoyanidi, and R.G. Discipio The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrum Immunology 135 2012 287 298
31. R. Horuk Chemokine receptor antagonists: overcoming developmental hurdles Nat. Rev. Drug Discov. 8 2009 23 33
32. T. Kitamura, T. Fujishita, P. Loetscher, L. Revesz, H. Hashida, S. Kizaka-Kondoh, and et al. Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model Proc. Natl. Acad. Sci. U. S. A. 107 2010 13063 13068
33. D.J. Dairaghi, B.O. Oyajobi, A. Gupta, B. McCluskey, S. Miao, J.P. Powers, and et al. CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease Blood 120 2012 1449 1457
34. J.-L. Gao, T.A. Wynn, Y. Chang, E.J. Lee, H.E. Broxmeyer, S. Cooper, and et al. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1 J. Exp. Med. 185 1997 1959 1968
35. L. Boring, J. Gosling, S.W. Chensue, S.L. Kunkel, R.V.J. Fareser, H.E. Broxmeyer, and et al. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice J. Clin. Invest. 100 1997 2552 2561
36. T. Sullivan, Z. Miao, D.J. Dairaghi, A. Krasinski, Y. Wang, B.N. Zhao, and et al. CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice Am. J. Physiol. Renal. Physiol. 305 2013 F1288 F1297
37. M. Gouwy, S. Struyf, N. Berghmans, C. Vanormelingen, D. Schols, D. Van, and J. amme CXCR4 and CCR5 ligands cooperate in monocyte and lymphocyte migration and in inhibition of dual-tropic (R5/X4) HIV-1 infection Eur. J. Immunol. 41 2011 963 973
38. M. Gouwy, S. Struyf, S. Noppen, E. Schutyser, J.Y. Springael, M. Parmentier, and et al. Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events Mol. Pharmacol. 74 2008 485 495
39. T.J. Curiel, G. Coukos, L. Zou, X. Alvarez, P. Cheng, P. Mottram, and et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat. Med. 10 2004 942 949
40. N. Obermajer, R. Muthuswamy, K. Odunsi, R.P. Edwards, and P. Kalinski PGE(2)- induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment Cancer Res. 71 2011 7463 7470
41. S.L. Highfill, Y. Cui, A.J. Giles, J.P. Smith, H. Zhang, E. Morse, and et al. Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy Sci. Transl. Med. 6 May (237) 2014 237 267
42. S.V. Novitskiy, M.W. Pickup, A.E. Gorska, P. Owens, A. Chytil, M. Aakre, and et al. TGF-β receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms Cancer Discov. 1 2011 430 441
43. W. Tan, W. Zhang, A. Strasner, S. Grivennikov, J.Q. Cheng, R.M. Hoffman, and et al. Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signaling Nature 470 2011 548 553
44. F.R. Balkwill The chemokine system and cancer J. Pathol. 226 2012 148 157
45. J.B. Mitchem, D.J. Brennan, B.L. Knolhoff, B.A. Belt, Y. Zhu, D.E. Sanford, and et al. Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses Cancer Res. 73 2013 1128 1141
46. R. Hughes, B.Z. Qian, C. Rowan, M. Muthana, I. Keklikoglou, O.C. Olson, and et al. Stimulation of tumor relapse after chemotherapy by perivascular, alternatively activate macrophages Cancer Res. 2015 (in press)
47. S. Acharyya, T. Oskarsson, S. Vanharanta, S. Malladi, J. Kim, P.G. Morris, and et al. A CXCL1 paracrine network links cancer chemoresistance and metastasis Cell 150 2012 165 178
48. Y. Zhu, B.L. Knolhoff, M.A. Meyer, T.M. Nywening, B.L. West, J. Luo, and et al. CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models Cancer Res. 74 2014 5057 5069
49. A.M. Lesokhin, T.M. Hohl, S. Kitano, C. Cortez, D. Hirschhorn-Cymerman, F. Avogadri, and et al. Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment Cancer Res. 72 2012 876 886
50. S. Su, Q. Liu, J. Chen, J. Chen, F. Chen, C. He, and et al. A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis Cancer Cell 25 2014 605 620
51. Q. Zhang, J. Qin, L. Zhong, L. Gong, B. Zhang, and Y. Zhang CCL5-mediated Th2 immune polarization promotes metastasis in luminal breast cancer Cancer Res. 2015 (in press)
52. C. Frankenberger, D. Rabe, R. Bainer, D. Sankarasharma, K. Chada, and T. Krausz Metastasis suppressors regulate the tumor microenvironment by blocking recruitment of pro-metastatic tumor-associated macrophages Cancer Res. 2015 (in press)